Ultra-sensitive CAR T cells eliminate solid tumours in mice
Engineered ultra-sensitive CAR T cells that detect very low levels of the CD70 antigen eliminated kidney, ovarian and pancreatic tumours in mice; the researchers plan to seek funding for a phase I safety trial in humans.
